Overview

A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a randomised study divided into 2 parts. Part A investigates the effect of prolonged dosing (ten days) with Avibactam and Ceftazidime when given together and how this will effect how much Avibactam and Ceftazidime enters the blood. Part B investigates how much Avibactam (NXL104) and Ceftazidime enter the blood when Avibactam and Ceftazidine are given separately or together intravenously.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Pfizer
Treatments:
Avibactam
Ceftazidime